Monosialoganglioside GM1 reduces ischemia - Reperfusion-induced injury in the rat retina

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 2, 1996, Pages 267-273

  Weber, Michel ^a   Mohand Said, Saddek ^b   Hicks, David ^b   Dreyfus, Henri ^b   Sahel, José Alain ^b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Ganglioside; GM1; Ischemia; Protection; Retina

Indexed keywords

GANGLIOSIDE; MONOSIALOGANGLIOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; HISTOPATHOLOGY; INTRAOCULAR PRESSURE ABNORMALITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; REPERFUSION INJURY; RETINA INJURY; RETINA ISCHEMIA; SURVIVAL TIME;

ANIMALS; APOPTOSIS; CELL COUNT; CELL DEATH; DISEASE MODELS, ANIMAL; G(M1) GANGLIOSIDE; INJECTIONS, INTRAPERITONEAL; ISCHEMIA; RATS; REPERFUSION; REPERFUSION INJURY; RETINA; RETINAL ARTERY; RETINAL DISEASES;

EID: 0030056366     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem. 1963;10:613-623.
2. Nagai Y. Functional roles of gangliosides in bio-signaling. Behav Brain Res. 1995;66:99-104.
3. Qi Y, Xue QM. Ganglioside levels in hypoxic brains from neonatal and premature infants. Mol Chem Neuropathol. 1991;14:87-97.
4. Tettamanti G, Venerando B, Roberti S, et al. The fate of exogenously administered brain gangliosides. In: Rapport MM, Gorio A, eds. Gangliosides in Neurological and Neuromuscular Function, Development and Repair. New York: Raven Press; 1981:225-240.
5. Karpiak SE, Mahadik SP, Wakade CG. Gangliosides reduction of ischemic injury. Crit Rev Neurobiol. 1990;5:221-237.
6. Lazzaro A, Seren MS, Koga T, Zanoni R, Schiavo N, Manev H. GM1 reduces infarct volume after focal cerebral ischemia. Exp Neurol. 1994;125:278-285.
7. Mazzari S, Karpiak SE, Lipartiti M, et al. Monosialoganglioside effects on excitatory amino acid-related neurotoxicity and cerebral ischemia. In: Guidotti A, ed. Neurotoxicity of Excitatory Amino Acids. New York: Raven Press; 1990:281-291.
8. Seren MS, Lazzaro A, Yang CL, et al. Orally administered glycolipid derivative LIGA20 reduces infarct volume and behavioral impairment after focal cerebral ischemia. J Pharmacol Exp Ther. 1994;263:460-465.
9. Simon RP, Chen J, Graham SH. GM1 ganglioside treatment of focal ischemia: A dose-response and microdialysis study. J Pharmacol Exp Ther. 1993;265:24-29.
10. Mahadik SP, Hawver DB, Hungund BL, Li YS, Karpiak SE. GM1 ganglioside treatment after global ischemia protects changes in membrane fatty acids and properties of Na+, K+-ATPase and Mg2+-ATPase. J Neurosci Res. 1989;24:402-412.
11. Favaron M, Manev H, Vicini S, Guidotti A, Costa E. Prevention of excitatory amino acid-induced neurotoxicity by natural and semisynthetic sphingoglycolipids. In: Guidotti A, eds. Neurotoxicity of Excitatory Amino Acids. New York: Raven Press; 1990:243-258.
12. Lombardi G, Moroni F. GM1 ganglioside reduces ischemia-induced excitatory amino acid output: Microdialysis study in the gerbil hippocampus. Neurosci Lett. 1992;134:171-174.
13. Magal E, Louis J-C, Aguilera J, Yavin E. Gangliosides prevent ischemia-induced down-regulation of protein kinase C in fetal rat brain. J Neurochem. 1990;55:2126-2131.
14. Mahadik SP, Hungund BL, Gokhale VS, et al. Monosialoganglioside (GM1) restores membrane fatty acid levels in ischemic tissue after cortical focal ischemia in rat. Neurochem Int. 1993;23:163-172.
15. Manev H, Favaron M, Vicini S, Guidotti A. Ganglioside-mediated protection from glutamate-induced neuronal death. Acta Neurobiol Exp. 1990;50:381-394.
16. Doherty P, Dickson JG, Flanigan TP, Walsh S. Ganglioside GM1 does not initiate, but enhances neurite regeneration of nerve growth factor-dependent sensory neurones. J Neurochem. 1985;44:1259-1265.
17. Katoh-Semba R, Skaper SD, Varon S. Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: Serum- and NGF-dependent effects on neuritic growth (and proliferation). J Neurosci Res. 1984;12: 299-310.
18. Leon A, Benvegnu D, Dal Toso R, et al. Dorsal root ganglia and nerve growth factor: A model for understanding the mechanism of GM effect on neuronal repair. J Neurosci Res. 1984;12:277-287.
19. Nieto-Sampedro M, Cotman CW. Growth factor induction and temporal order in central nervous system repair. In: Cotman CW, ed. Synaptic Plasticity. New York: The Guilford Press; 1986:407-455.
20. Kumon Y, Sakaki S, Kadota O, et al. Transient increase in endogenous basic fibroblast growth factor in neurons of ischemic rat brains. Brain Res. 1993;605:169-174.
21. Sautter J, Schwartz M, Duvdevani R, Sabel BA. GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve. Brain Res. 1991; 565:23-33.
22. Yoles E, Zalish M, Lavie V, et al. GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve. Invest Ophthalmol Vis Sci. 1992; 33:3586-3591.
23. Michon JJ, Li ZL, Shioura N, Anderson RJ, Tso MOM. A comparative study of methods of photoreceptor morphometry. Invest Ophthalmol Vis Sci. 1991;32:280-284.
24. Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res. 1990;53:573-582.
25. Büchi ER, Suivaizdis I, Fu J. Pressure-induced retinal ischemia in rats: An experimental model for quantitative study. Ophthalmologica. 1991;203:138-147.
26. Unoki K, Lavail M. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci. 1994;35:907-915.
27. Hamassaki-Britto DE, Hermans-Borgmeyer I, Heinemann S, Hughes TE. Expression of glutamate receptor genes in the mammalian retina: The localisation of Glu.R-1 through Glu.R-7 mRNA. J Neurosci. 1993;13:1888-1898.
28. Brandstäter JH, Hartveit E, Sassoè-Pognetto M, Wässle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci. 1994;6:1100-1112.
29. Abrams L, Politi LE, Adler R. Differential susceptibility of isolated mouse retinal neurons and photoreceptors to kainic acid toxicity. Invest Ophthalmol Vis Sci. 1989;30:2300-2308.
30. Siliprandi R, Canella R, Carmignoto G, et al. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992;8:567-573.
31. Kanno C, Ishiguro S, Shiono T, Kikuchi M, Tamai M. Decrease of opsin content in the developing rat photoreceptor cells by systemic administration of L-glutamate. Cell Struct Funct. 1991;16:399-403.
32. Edel-Harth S, Dreyfus H, Bosch P, et al. Gangliosides of whole retina and rod outer segments. FEBS Lett. 1973;35:284-288.
33. Diez-Tegedor E, Guttierrez-Riva E, Gil-Peralta A. Gangliosides and Guillain-Barré syndrome: The Spanish data. Neuroepidemiology. 1993;12:251-256.
34. Simone IL, Annunciata P, Maimoné D, et al. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré sydrome and chronic inflammatory demyelinative polyneuropathy. J Neurol Sci. 1993;114:49-55.
35. Crosson CE, Willis JA, Potter DE. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J Ocul Pharmacol. 1990;6:293-299.
36. Takahashi K, Lam TT, Edward DP, Büchi ER, Tso MOM. Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol. 1992; 110:862-870.
37. Yoon YH, Marmor MF. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol. 1989;107:409-411.
38. Mosinger JL, Price MT, Bai HY, et al. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol. 1991;113:10-17.
39. Weber M, Bonaventure N, Sahel JA. Protective role of excitatory amino acid antagonists in experimental retinal ischemia. Graefe's Arch Clin Exp Ophthalmol. 1995;233:360-365.
40. El-Asrar AMA, Morse PH, Maimoné D, Torczynski E, Reder AT. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest Ophthalmol Vis Sci. 1992;33:3463-3468.
41. Gupta LY, Marmor MF. Mannitol, dextromethorphan, and catalase minimize ischemic damage to the retinal pigment epithelium and retina. Arch Ophthalmol. 1993;111:384-388.
42. Szabo ME, Droy-Lefaix MT, Doly M, Carré C, Braquet P. Ischemia and reperfusion-induced histologic changes in the rat retina. Invest Ophthalmol Vis Sci. 1991;32:1471-1478.
43. Nayak MS, Kita M, Marmor MF. Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase. Invest Ophthalmol Vis Sci. 1993;34:2018-2022.
44. Zhang C, Takahashi K, Lam TT, Tso MOM. Effects of basic fibroblast growth factor in retinal ischemia. Invest Ophthalmol Vis Sci. 1994;35:3163-3168.